EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular Capture of Mycobacterium tuberculosis Genomes Directly from Clinical Samples: A Potential Backup Approach for Epidemiological and Drug Susceptibility Inferences

Rita Macedo iD, Joana Isidro iD, Rita Ferreira iD, Miguel Pinto, Vítor Borges iD, Sílvia Duarte, Luís Vieira, João Paulo Gomes iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24032912 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Rita Macedo und 7 weiteren Autor:innen. Beteiligte Einrichtung: National Reference Laboratory for Mycobacteria, Department of Infectious Diseases, National Institute of Health (INSA), 1649-016 Lisbon, Portugal. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Tuberculosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Centre for Disease Control and Prevention, GenomePT project, COMPETE 2020—Operational Programme for Competitiveness and Internationalisation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The application of whole genome sequencing of Mycobacterium tuberculosis directly on clinical samples has been investigated as a means to avoid the time-consuming need for culture isolation that can lead to a potential prolonged suboptimal antibiotic treatment. We aimed to provide a proof-of-concept regarding the application of the molecular capture of M. tuberculosis genomes directly from positive sputum samples as an approach for epidemiological and drug susceptibility predictions. Smear-positive sputum samples (n = 100) were subjected to the SureSelectXT HS Target Enrichment protocol (Agilent Technologies, Santa Clara, CA, USA) and whole-genome sequencing analysis. A higher number of reads on target were obtained for higher smear grades samples (i.e., 3+ followed by 2+). Moreover, 37 out of 100 samples showed ≥90% of the reference genome covered with at least 10-fold depth of coverage (27, 9, and 1 samples were 3+, 2+, and 1+, respectively). Regarding drug-resistance/susceptibility prediction, for 42 samples, ≥90% of the >9000 hits that are surveyed by TB-profiler were detected. Our results demonstrated that M. tuberculosis genome capture and sequencing directly from clinical samples constitute a potential valid backup approach for phylogenetic inferences and resistance prediction, essentially in settings when culture is not routinely performed or for samples that fail to grow.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisTuberculosisHumansAntitubercular AgentsPhylogenyWhole Genome SequencingSputumMicrobial Sensitivity Tests

Stichwörter der Autor:innen

Mycobacterium tuberculosisRNA-baitsmolecular captureresistancesurveillancetarget enrichmentwhole genome sequencing

Substanzen

Antitubercular Agents

Autor:innen und Institutionen

  • National Reference Laboratory for Mycobacteria, Department of Infectious Diseases, National Institute of Health (INSA), 1649-016 Lisbon, Portugal.
  • Genomics and Bioinformatics Unit, Department of Infectious Diseases, National Institute of Health (INSA), 1649-016 Lisbon, Portugal.
  • Innovation and Technology Unit, National Institute of Health (INSA), 1649-016 Lisbon, Portugal.

ORCID-Profile: Rita Macedo, Joana Isidro, Rita Ferreira, Vítor Borges, João Paulo Gomes

Förderung

  • European Centre for Disease Control and Prevention
  • GenomePT project
  • COMPETE 2020—Operational Programme for Competitiveness and Internationalisation
  • Lisboa Portugal Regional Operational Programme
  • Algarve Portugal Regional Operational Programme
  • European Regional Development Fund (ERDF)
  • Fundação para a Ciência e a Tecnologia (FCT)

Zitieren

APA

Macedo, R., Isidro, J., Ferreira, R., Pinto, M., Borges, V., Duarte, S., Vieira, L., & Gomes, J. P. (2023). Molecular Capture of Mycobacterium tuberculosis Genomes Directly from Clinical Samples: A Potential Backup Approach for Epidemiological and Drug Susceptibility Inferences. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24032912

Vancouver

Macedo R, Isidro J, Ferreira R, Pinto M, Borges V, Duarte S, et al. Molecular Capture of Mycobacterium tuberculosis Genomes Directly from Clinical Samples: A Potential Backup Approach for Epidemiological and Drug Susceptibility Inferences. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24032912

BibTeX
@article{Macedo2023,
  author = {Macedo, Rita and Isidro, Joana and Ferreira, Rita and Pinto, Miguel and Borges, Vítor and Duarte, Sílvia and Vieira, Luís and Gomes, João Paulo},
  title = {Molecular Capture of Mycobacterium tuberculosis Genomes Directly from Clinical Samples: A Potential Backup Approach for Epidemiological and Drug Susceptibility Inferences},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24032912}
}
Kostenlos starten →